BOCA RATON, Fla., Aug. 1 /PRNewswire-FirstCall/ -- Eclipsys Corporation(R) , The Outcomes Company(R), today announced it has a signed a new contract with the University of Pennsylvania Health System (UPHS). The agreement consists of an extension of the current agreement to provide high- acuity clinical information solutions as well as additional solutions, including Sunrise Pharmacy(TM), Knowledge-Based Medication Administration(TM), Knowledge-Based Charting(TM), and Zynx Health's evidence-based order sets.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO )
The new contract supports UPHS' objective to create an electronic longitudinal medical record for each patient accessing the health system. This electronic record will facilitate improved patient care, more accurate outcomes reporting and serve as a foundation for the development of an institutional data repository to allow UPHS researchers easy access to all patient data.
To help reduce medication errors, UPHS will add Sunrise Pharmacy and Knowledge-Based Medication Administration to its existing implementation of Eclipsys' Knowledge-Based CPOE(TM) system. The health system will then have automated end-to-end medication management workflows, including physicians as they place orders, pharmacists as they dispense orders and nurses as they administer medications.
The new contract also includes Eclipsys' evidence-based content and Zynx Health's evidence-based order sets to help UPHS standardize on proven care delivery processes across its inpatient facilities, which includes the Hospital of the University of Pennsylvania, Pennsylvania Hospital, and Penn Presbyterian Medical Center.
"UPHS is one of the most respected health systems in the country, and it's truly an honor that the organization made such a significant new investment with Eclipsys. This represents the largest renewal and expansion contract signed in our company's history," said R. Andrew Eckert, Eclipsys' president and chief executive officer. "UPHS' success with Sunrise Clinical Manager 4.5 reflects the exceptionally high client satisfaction rates for the latest version of our integrated clinical information solution, and is a testament to our continued hard work to make our clients successful. Additionally, the health system's purchase of additional solutions suggests that our company's focus on better understanding our existing client's needs in order to increase our product footprint is delivering results."
UPHS will also engage Eclipsys professional services to help make sure all new implementations are delivered on-time and on-budget and to help the health system achieve high adoption rates for all Eclipsys solutions.
Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and access management software, clinical content and professional services that help healthcare organizations improve clinical, financial, operational and customer-satisfaction outcomes. For more information, see firstname.lastname@example.org or email .
Statements in this news release concerning the benefits provided by Eclipsys software, content and implementation services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client's circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from software, content or services. The success and timeliness of the company's services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Clinical Manager, Sunrise Pharmacy, Knowledge-Based Medication Administration, Knowledge-Based Charting, and Knowledge-Based CPOE are trademarks of Eclipsys Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.
Eclipsys Jason Cigarran Director of Media Relations (media) (561) 322-4355 email@example.com Robert J. Colletti Chief Financial Officer (investors) (561) 322-4655
CONTACT: Media, Jason Cigarran, Director of Media Relations, firstname.lastname@example.org+1-561-322-4355, ; or Investors, Robert J.Colletti, Chief Financial Officer, +1-561-322-4655,, both of Eclipsys Corporation
Web site: http://www.eclipsys.com/